Agenus | AGEN - بدهکاران تجاری





بدهکاران تجاری تغییر دادن تاریخ
AbbVie USD 12.77B 132M 2025-09
Agenus USD 22.44M 1.14M 2025-12
Amgen USD 9.57B 1.08B 2025-12
AstraZeneca USD 19.05B 1.49B 2025-12
Bristol-Myers Squibb USD 14.62B 485M 2025-09
Celldex Therapeutics USD 2.02M 1.92M 2025-12
CSL USD 4.32B 1.35B 2025-12
Eli Lilly USD 19.46B 2.25B 2025-09
Gilead Sciences USD 4.91B 182M 2025-12
GlaxoSmithKline GBP 7.76B 545M 2025-12
Glaxosmithkline GBP 10.45B 707.81M 2025-12
Incyte USD 1.02B 128.52M 2025-12
Intrexon USD 1.02M 559K 2024-06
J&J USD 17.61B 235M 2025-09
Jiangsu Hengrui CNY 6.26B 64.96M 2025-09
Karyopharm Therapeutics USD 31.78M 6.82M 2024-09
MacroGenics USD 13.37M 55.86M 2025-12
Merck EUR 4.44B 293M 2025-12
Merck USD 12.12B 596M 2025-09
Novartis USD 12.29B 3.3B 2025-12
Novavax USD 106.45M 72.27M 2025-12
Pfizer USD 18.12B 2.02B 2025-09
Regeneron Pharmaceuticals USD 5.74B 54M 2025-12
Rigel Pharmaceuticals USD 28.9M 1.39M 2024-06
Sangamo BioSciences USD 581K 110K 2024-06
Veracyte USD 44.66M 3.17M 2025-12